Valganciclovir Hydrochloride Powder, For Solution
Product Images NDC 27241-159

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 27241-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Valgacyclovir Structure)

FDA Label Image

Valganciclovir 50mg

Valganciclovir for oral solution is a prescription medication that comes in an original bottle that is child-proof. The dry powder can be stored at room temperature, while the solution should be kept refrigerated. Once the solution is constituted, it should be used within 49 days of preparation. The constituted oral solution should be handled with care and the original bottle should be tightly closed. The solution has a Net contents of 100 mL, containing 5 grams of Valganciclovir free base. To dispense, prepare the solution at the time of dispensing by measuring 91 mL of purified water.*

FDA Label Image

Valganciclovir Carton

The text provides instructions for preparing and using Valganciclovir for oral solution to treat cytomegalovirus. It includes information about measuring the powder, adding water, shaking, and the proper storage and use of the solution after mixing. The solution contains 50mg of Valganciclovir per mL and should be used within 49 days after preparation. The product is made by Ajanta Pharma USA Inc. and includes dry powder, a bottle adapter, and two oral dispensers. The text also provides dosage information and warnings about proper storage, and suggests referring to enclosed patient instructions for use.*

FDA Label Image

Valganciclovir Fig1

FDA Label Image

Formula2 (Valganciclovir Image2)

This text describes a formula to calculate creatinine clearance based on the patient's height and serum creatinine levels. However, the value of "k" is not provided in the text.*

FDA Label Image

Valganciclovir Step1

FDA Label Image

Valganciclovir Step10

FDA Label Image

Valganciclovir Step11

FDA Label Image

Valganciclovir Step2

FDA Label Image

Valganciclovir Step3

FDA Label Image

Valganciclovir Step4

FDA Label Image

Valganciclovir Step5

FDA Label Image

Valganciclovir Step6

FDA Label Image

Valganciclovir Step7

FDA Label Image

Valganciclovir Step8

FDA Label Image

Valganciclovir Step9

FDA Label Image

Formula- (Valgavcyclovir Formula 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.